0001209191-23-049366.txt : 20230913 0001209191-23-049366.hdr.sgml : 20230913 20230913201619 ACCESSION NUMBER: 0001209191-23-049366 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230911 FILED AS OF DATE: 20230913 DATE AS OF CHANGE: 20230913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Lara CENTRAL INDEX KEY: 0001769457 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40881 FILM NUMBER: 231253847 MAIL ADDRESS: STREET 1: C/O REXAHN PHARMACEUTICALS, INC. STREET 2: 15245 SHADY GROVE ROAD, SUITE 455 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pyxis Oncology, Inc. CENTRAL INDEX KEY: 0001782223 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831160910 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 HARRISON AVENUE CITY: BOSTON STATE: MA ZIP: 02118 BUSINESS PHONE: (617) 221-9059 MAIL ADDRESS: STREET 1: 321 HARRISON AVENUE CITY: BOSTON STATE: MA ZIP: 02118 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-09-11 0 0001782223 Pyxis Oncology, Inc. PYXS 0001769457 Sullivan Lara C/O PYXIS ONCOLOGY, INC. 321 HARRISON AVENUE BOSTON MA 02118 1 1 0 0 President and CEO 0 Common Stock 2023-09-11 4 S 0 20000 2.2707 D 2605182 D Common Stock 2023-09-12 4 S 0 4917 2.2516 D 2600265 D Common Stock 2023-09-13 4 S 0 3000 2.2719 D 2597265 D Common Stock 2023-09-13 4 F 0 184742 2.13 D 2412523 D Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 2 through 4 of this Form 4. The transaction was executed in multiple trades in prices ranging from $2.13 to $2.36. The transaction was executed in multiple trades in prices ranging from $2.21 to $2.30. The transaction was executed in multiple trades in prices ranging from $2.25 to $2.34. Represents shares withheld to cover taxes due upon the vesting of certain restricted stock units. /s/ Pamela Connealy, Attorney-in-Fact for Lara Sullivan 2023-09-13